Recombinant adenoviruses provide a versatile system for gene expression studies and therapeutic applications. We have developed an approach that simplifies the generation and production of such viruses called the AdEasy system. A recombinant adenoviral plasmid is generated with a minimum of enzymatic manipulations, employing homologous recombination in bacteria rather than in eukaryotic cells. After transfection of such plasmids into a mammalian packaging cell line, viral production is conveniently followed with the aid of GFP encoded by a gene incorporated into the viral backbone. This system has expedited the process of generating and testing recombinant adenoviruses for a variety of purposes. In this protocol, we describe the practical aspects of using the AdEasy system for generating recombinant adenoviruses. The full protocol usually takes 4-5 weeks to complete.
INTRODUCTION

Effective gene delivery mediated by recombinant adenovirus
Recombinant adenoviruses are replication-defective adenoviral vectors that have proven useful for gene therapy, vaccine therapy and basic biology [1] [2] [3] [4] [5] [6] [7] . Several features of recombinant adenoviruses make them particularly appealing as vectors for gene transfer. For example, high-titer preparations of adenoviruses can be readily prepared and used to achieve a high level of transgene expression in a broad spectrum of host cells and tissues, including non-dividing cells.
The most commonly used adenoviral vectors are derived from human adenovirus serotypes 2 and 5. Adenoviruses are nonenveloped DNA viruses whose capsid is composed of pentons and hexons. The viral genome consists of 36-kb double-stranded linear DNA with inverted terminal repeat (ITR) sequences at each end. DNA of length greater than 38 kb cannot be efficiently packaged into competent viral particles. The adenovirus life cycle begins with the attachment of the fiber to cell surface receptors, such as coxsackievirus and adenovirus receptor, and the interaction of the pentons with a v b 3 and a v b 5 integrin proteins. Following receptor-mediated endocytosis, adenovirus escapes from the endosomes to the cytoplasm and translocates into the nucleus, where viral transcription and replication begin. Completion of the virus life cycle triggers cell death and the release of progeny viruses. On the basis of temporal expression relative to the onset of viral DNA replication, viral transcription units are conventionally referred to as early (E1a, E1b, E2, E3 and E4), delayed early (proteins IX and Iva2) or late genes (L1-L5). The early gene products are generally involved in viral gene transcription, DNA replication, host immune suppression and inhibition of host cell apoptosis, whereas the late gene products are required for virion assembly 8 .
Replication-defective adenoviruses and biosafety issues
The complexity of adenoviral transcription units limits most recombinant manipulations to specific regions not essential for viral production, such as E1, E2A, E3 and E4. First-generation adenoviral vectors replaced E1 genes with the desired transgene [denoted hereinafter as gene of interest (GOI)]. Such E1-deleted vectors could be propagated in cell lines that express E1 gene products, such as HEK-293 cells 9 . However, these vectors had relatively limited packaging capacity 10 . Second-generation adenoviral vectors accommodated larger transgenes, reduced the cytotoxic effects in host cells and diminished the ability to elicit host immune response. For example, adenoviral vectors with deletions in E1, E3 and E4 (DE1, DE3 and DE4) could accommodate up to 10 kb foreign DNA [4] [5] [6] [7] . Moreover, adenoviral vectors with deletions of E1 and E2 could prolong transgene expression and reduce cytotoxic effects [4] [5] [6] . Although E3 is not essential for viral replication, specific packaging lines expressing the other deleted genes were required. In the extreme case, the whole adenoviral genome (except ITRs and the packaging signal sequences) was replaced by exogenous sequences, resulting in so-called gutted or gutless vectors, and the gene products required for viral replication and packaging were provided in trans [4] [5] [6] 11 . Gutless adenoviral vectors accommodated up to 35 kb foreign DNA, exhibited significantly reduced host immune responses and achieved long-term expression of multiple transgenes in a single vector [4] [5] [6] . Overall, there are several examples of the construction and use of conditionally replicating adenoviruses that promise delivery to specific cell types in vivo [4] [5] [6] [7] . In this protocol, we primarily focus on viruses with a deletion of both E1 and E3 (DE1, DE3).
The generation and production of recombinant adenoviruses should be performed in a laboratory operating at Biosafety Level 2 (BL2), as approved by the researcher's institutional biosafety committee and following the National Institutes of Health Biosafety guidelines (http://www.cdc.gov/od/ohs/biosfty/bmbl4/bmbl4toc.htm). These requirements include the use of biosafety cabinet hoods, the establishment of proper procedures for decontamination and disposal of liquid and solid wastes and the disinfection of contaminated surfaces and equipment. In addition, users should conduct a regular analysis of adenovirus stocks to exclude the presence of replicationcompetent adenoviruses in their preparations.
Methods for generating recombinant adenoviruses Three general approaches have been employed to generate recombinant adenoviruses. The first approach involves direct ligation of DNA fragments of the adenoviral genome to restriction endonuclease fragments containing transgenes [1] [2] [3] [4] [5] [6] [7] . The difficulty of purifying large viral genomic DNA fragments, the low efficiency of large fragment ligations and the relative paucity of unique restriction sites in the adenoviral genome have made this approach unpopular. The second method uses site-specific recombinases. One useful example of such a method employs the Cre recombinase/loxP sitespecific recombination system [4] [5] [6] 12 . The third and most widely used method involves homologous recombination in mammalian cells or in microorganisms. This method requires a two-vector system, namely 'shuttle' and 'backbone' plasmids 13 . A typical shuttle vector usually contains the 5¢ end of the adenoviral genome in which E1 and other non-essential genes are replaced with a transgene. The resultant shuttle vector is subsequently recombined into the 'backbone' vector. This backbone provides most of the adenovirus genome but lacks genes essential for virus propagation in naturally occurring cells. After recombination, a single DNA molecule encoding all the genes necessary for virus production in packaging cells (but not in naturally occurring cells) is produced. Traditionally, the recombination process was achieved through homologous recombination in mammalian cells 13 . However, this proved to be the rate-limiting step in the production of recombinant adenoviruses owing to the inefficient and somewhat unpredictable nature of homologous recombination in mammalian cells. Yeast and bacterial systems have, therefore, been explored for this purpose 11, 12, [14] [15] [16] [17] [18] [19] [20] . Once a DNA molecule incorporating both the backbone and shuttle vector sequences has been generated in such microbial systems, the cloned DNA can be transfected into mammalian packaging lines for virus production. These approaches have made it possible to generate large quantities of recombinant adenoviruses in a timely and predictable fashion.
The AdEasy system described in this protocol exploits the high efficiency of homologous recombination in a specific bacterial strain coupled with selectable antibiotic resistance markers to simplify recombinant vector production 4, 7, 20 .
The AdEasy system for regenerating recombinant adenoviruses As outlined in Figure 1 and in TIMING, the AdEasy technology consists of three steps. (i) Subclone GOI into a shuttle vector (e.g., pAdTrack-CMV). (ii) Introduce the linearized shuttle vector into a strain of BJ5183 bacterial cells that harbors the supercoiled backbone vector (AdEasier cells). BJ5183 bacterial cells are deficient in certain enzymes that mediate recombination in bacteria (endA, sbcB-, recBC-, str R ) 21 but still permit efficient generation of stable homologous recombinants. (iii) Transfect PacI-digested recombinant adenoviral DNA into HEK-293 cells and harvest viruses 14-20 d later.
Vectors for use in the AdEasy system The AdEasy system can be used with any of four shuttle vectors. As shown in Figure 2a , pShuttle is the basic vector with the greatest capacity for accommodating foreign genes and/or the flexibility to customize a promoter for transgene expression. The pShuttle-CMV vector contains a cytomegalovirus (CMV) promoter to drive expression of the GOI. Both pAdTrack and pAdTrack-CMV incorporate an independent cassette expressing a GFP marker for convenient assessment of adenovirus transducing efficiency. However, these two vectors have a reduced capacity for accommodating foreign genes.
Two adenoviral backbone vectors can be used for adenovirus production (Fig. 2b) . The commonly used pAdEasy-1 is an E1 and E3 double-deletion vector. Hence, AdEasy-1-derived recombinant adenoviruses can be propagated in E1-expressing packaging cells, such as HEK-293 cells (E3 is not necessary for viral production). The pAdEasy-2 backbone vector is an E1, E3 and E4 triple-deletion vector 7, 20 . Thus, propagation of AdEasy-2-derived vectors requires the use of packaging cell lines expressing both E1 and E4. As the E4 gene product is toxic to mammalian cells, its expression is usually controlled by inducible promoters. Several such E1/E4 packaging lines are available. However, because of the leakiness of most inducible systems, high E4-expressing cells are often lost after serial passages, and it is difficult to generate high-titer AdEasy-2-derived viruses. Thus, in this protocol we focus on procedures for generating recombinant adenoviruses with the AdEasy-1 system. For investigators wishing to express particularly long (or multiple) transgenes, we recommend gutless systems. Unlike AdEasy vector systems, which can tolerate replacements in the E1 and E4 regions only, gutless systems can tolerate much larger replacements in the adenoviral backbone [4] [5] [6] 11 . Although the AdEasy system has been made freely available to thousands of academic researchers, the system can also be obtained through commercial sources listed on the AdEasy website (http://www.coloncancer.org/adeasy.htm). adenovirus generation and subsequent amplification should be performed in accordance with the BL2 guidelines. All cell culture incubations are performed in a humidified 37 1C, 5% CO 2 incubator unless otherwise specified. All solutions, reagents and equipment coming into contact with cells must be sterile, and proper sterile and antiseptic techniques should be used accordingly. Biohazard wastes containing adenoviruses should be disinfected with chlorine bleach.
MATERIALS
. 15 polymerase. In some cases, it may be more convenient to introduce new restriction sites at one or both ends by linker ligation or by PCR amplification. Introduction of restriction sites by PCR is quick and efficient, but the sequence of the amplified segments must be verified by DNA sequencing. m CRITICAL STEP Confirm the presence and orientation of the GOI by restriction analysis and/or PCR amplification and/or sequencing (vector maps and sequences can be found at the AdEasy website; http://www.coloncancer.org/adeasy. htm). m CRITICAL STEP If pShuttle or pAdTrack is chosen, users have to provide a promoter and a polyadenylation signal for the transgene expression cassette. For all shuttle vectors, it is important to include a consensus Kozak signal sequence for efficient transgene expression. m CRITICAL STEP As PmeI or EcoRI is used to linearize the shuttle vector for transformation into bacteria and PacI is used to linearize the recombinant for transfection into the HEK-293 packaging line, these sites should be avoided in the inserts. If PacI is present, we recommend removing it through site-directed mutagenesis. If both PmeI and EcoRI are present in the insert, one of the two sites should be removed through site-directed mutagenesis. m CRITICAL STEP If multiple gene expression cassettes are desired, it is critical to avoid cloning the same elements (such as a CMV promoter) in a head-to-head orientation. Deletion of the sequences between the two repeated elements may occur during homologous recombination when oriented in this fashion. The problem can be avoided by placing the repetitive elements in a head-to-tail orientation. m CRITICAL STEP We strongly recommend that transgene expression from the shuttle vectors be confirmed by transient transfection into a suitable cell line (e.g., HEK-293 cells) before proceeding with the next step. Most problems that have been encountered by users have been due to unanticipated problems at this stage.
Generating recombinant adenovirus plasmids using AdEasier cells 2| Obtain highly electrocompetent AdEasier cells and aliquot the cells at 20 ml per tube and freeze at À80 1C. AdEasier cells can be prepared in the user's own lab by transforming pAdEasy-1 into competent BJ5183 cells 22 . Alternatively, AdEasier cells purchased from Stratagene can be grown and used to prepare electrocompetent bacteria. At the time of transformation, thaw aliquots and keep on ice. m CRITICAL STEP The use of high-quality electrocompetent AdEasier cells is essential for the efficient generation of adenovirus recombinants because BJ5183 cells exhibit lower transformation efficiency than most conventional strains used for molecular cloning. 3| Grow shuttle plasmid clones containing the GOI in 2 ml LB/kanamycin in a 15-ml conical tube, shaking overnight in a 37 1C orbital shaker. Purify plasmid DNA. We recommend that you use an alkaline lysis procedure 7 . Note: All shuttle vectors confer resistance to kanamycin. m CRITICAL STEP For efficient homologous recombination in AdEasier cells, it is critical to maintain the integrity of the shuttle vector DNAs. We have found that plasmids purified with commercial DNA minipreparation kits contain significant numbers of nicked DNA molecules that are detrimental to efficient and faithful recombination. The conventional alkaline lysis procedure has given us the most consistent and reliable results.
4| Linearize the confirmed shuttle vector with either PmeI or EcoRI restriction endonuclease. To ensure complete digestion, use a 100-ml reaction with 0.1-0.5 mg DNA and 30-100 U of enzyme. Ensure that the digestion is complete by electrophoresis in an agarose gel. One-tenth to one-fifth of each miniprep (approximately 0.1-0.5 mg DNA) is sufficient for one transformation of AdEasier cells.
5|
To the 100-ml DNA restriction solution, add 100 ml ddH 2 O, 100 ml 7.5 M ammonium acetate and 2 ml seeDNA carrier (or 2 ml 20 mg ml À1 glycogen). Extract with 300 ml 25:24:1 phenol/chloroform/isoamyl alcohol, pH 8.0.
6| Transfer the top layer of DNA solution to a clean tube and precipitate with 600 ml 100% ethanol by centrifuging for 5 min at 16,000g at room temperature (251C). Wash the pellet three times with 70% ethanol to eliminate residual salt. Re-suspend DNA in 8 ml ddH 2 O. m CRITICAL STEP Do not gel-purify the linearized shuttle vector because the purification process may reduce the transformation efficiency, and more importantly, may introduce undesired nicks in the DNA. 10| Pick 10-20 of the smallest colonies (Fig. 3a) from well-isolated and evenly plated areas (Fig. 3a) . We have attempted to screen for potential recombinants by PCR using primers across the recombination junctions and found that it is not very helpful because of a high false-positive rate. m CRITICAL STEP If the background is high (too many large clones), consider one of the following options. (i) Do not incubate the bacteria mix after electroporation at 37 1C; instead, directly plate them on LB/kanamycin plates; (ii) reduce the amount of shuttle vector used for transformation or (iii) minimize the possibility of introducing nicks into the shuttle vector DNA (e.g., use the alkaline lysis procedure to prepare the shuttle plasmids). m CRITICAL STEP The BJ5183 culture should not be grown for longer than 24 h in light of the higher frequency of recombination and rearrangement of large plasmids in BJ5183 cells.
11| Perform minipreps. We recommend you use the conventional alkaline lysis method 7 . Check the size of supercoiled plasmids by running one-fifth of each miniprep on a 0.8% agarose gel (Fig. 3b) . Perform PacI restriction digestion on candidate clones. Correct recombinants usually yield a large fragment (approximately 30 kb) and a smaller fragment of 3.0 or 4.5 kb (Fig. 3c) . m CRITICAL STEP The yield of recombinant DNA is much lower than that of background clones generated from unwanted recombination events (which generally appear as large colonies) or from residual uncut shuttle vector. After digesting the recombinants with PacI, the smaller fragment can be either 3.0 or 4.5 kb. Both types of clones are correct. The reason is that the homologous recombination can occur between the ori regions on the shuttle plasmid and AdEasy-1 or between the two homologous left arms (Fig. 1) . In the former case, PacI digestion will yield fragments of 30+ and 4.5 kb.
12| Retransform 1-3 ml of correct recombinant plasmids into DH10B (or other plasmid propagation strain not prone to recombination). Further restriction analysis of the clones should be performed to confirm their structure. Finally, purify plasmids with any commercial purification kit or by CsCl gradients in preparation for transfection of HEK-293 cells. m CRITICAL STEP Integrity of the transgenes in the final recombinant adenoviral plasmids should be analyzed by diagnostic restriction endonuclease digestions or through PCR amplification. m CRITICAL STEP Because of the higher frequency of recombination and rearrangement of large plasmids in BJ5183 cells, one should not attempt to re-grow the BJ5183 culture for the candidate recombinant clones. Instead, potential recombinant plasmids should be recovered from BJ5183 cells as early as possible (no later than 24 h) and transformed into a recombination-defective strain.
Generating recombinant adenoviruses in HEK-293 packaging cells 13| Plate HEK-293 cells in one or two 25-cm 2 tissue culture flask(s) at 2 Â 10 6 cells per flask 6-15 h before transfection. m CRITICAL STEP The cell confluency should be approximately 50%, but no higher than 70%, at the time of transfection. Do not transfect HEK-293 cells that were plated more than 24 h before transfection, regardless of confluency. Transfection of one flask is usually sufficient to generate viruses for further amplification. However, multiple flasks can be used for transfection if quicker viral amplifications are desired. Note: All cell culture work involved in adenovirus generation and subsequent amplification should be performed in accordance with BL2 guidelines.
14| Digest recombinant adenoviral plasmid with PacI (usually 3 mg DNA is needed to transfect one 25-cm 2 tissue culture flask). To ensure complete digestion, carry out restriction reactions in 100-ml volumes using 3 mg DNA and 30-100 U enzyme. Precipitate digested plasmids with ethanol and re-suspend in 20 ml sterile ddH 2 O.
15| Perform a standard transfection with LipofectAMINE according to manufacturer's instructions (as follows). Mix 3 mg
PacIdigested plasmid and 15 ml LipofectAMINE reagent for each 25-cm 2 tissue culture flask in 500 ml Opti-MEM I, and incubate the DNA/LipofectAMINE reagent mix for 15-30 min at room temperature. 17| Add DNA/LipofectAMINE mix dropwise to the 25-cm 2 tissue culture flasks, and return them to a 37 1C, 5% CO 2 humidified incubator. Remove the medium containing DNA/LipofectAMINE mix 4-6 h later and add 7-10 ml fresh complete DMEM. m CRITICAL STEP Do not change the DNA/LipofectAMINE medium if a significant number of floating cells are observed. Instead, add 6.0 ml complete DMEM to the flask and incubate at 37 1C for 8-12 h. Then change the medium and add 7-10 ml fresh medium to each 25-cm 2 tissue culture flask.
18|
If pAdTrack-based vectors are used, monitor transfection efficiency and virus production by GFP expression, which is visible under fluorescence microscopy (Fig. 4a) . (Fig. 4a) . The shapes of the fluorescent plaques depend on transfection efficiency. Low transfection efficiencies may produce 'comet-like' plaques, whereas high transfection efficiencies may produce an intense 'scattered stars' phenomenon.
19|
To prepare viral lysates, scrape cells off flasks with a cell scraper or rubber policeman (do not use trypsin) and transfer to 15-ml conical tubes. Centrifuge cells in a bench-top centrifuge for approximately 10 min at 500g at 4 1C. Remove all but 2.0 ml medium and re-suspend the pellet by vortexing. m CRITICAL STEP The virus is mostly attached to the cells, not released in the medium.
20| Perform four freeze-thaw-vortex cycles to release adenoviruses from cells, as follows: freeze cells in a dry-ice/methanol bath, thaw in a 37 1C water bath and vortex vigorously (i.e., 30 s). Repeat the freezing-thawing-vortexing for three more cycles. Centrifuge samples at 500g at 4 1C to pellet the cell debris. m CRITICAL STEP Remove tubes from water bath as soon as the samples are thawed to avoid warming the virus, as this can reduce viral titers. m CRITICAL STEP In most cases, it takes two to four rounds of amplification to generate a large-scale preparation of high-titer viruses. However, the number of amplification rounds is largely dependent on the initial titers of the lysates from the primary transfectants. ' PAUSE POINT Store viral lysates at À20 or À80 1C if they are not to be immediately used for infection of HEK-293 cells to amplify virus titers. Note: We have generally been able to generate adenoviruses suitable for experimental use in tissue culture without plaque purification. For more exacting applications, however, it is advisable to perform plaque purification. Homogeneity of adenoviruses can be judged by restriction endonuclease digestion, paying careful attention to the ratio of the fragments obtained (which should be molar if the viruses are homogeneous). We have not seen evidence of recombination within more than 50 adenoviruses produced with the AdEasy system. However, we cannot exclude subtle changes in sequence that may occur during the cloning or viral production steps. If such subtle changes are an issue, the GOI can be amplified from the final viral preparation using PCR and the sequence determined using conventional means.
Stepwise m CRITICAL STEP Volumes of the primary transfection lysates used in each infection are determined by their initial titers (usually in the range of 10 6 -10 8 infectious particles per ml). The rest of the viral lysate should be stored at À20 or À80 1C. A CPE or cell lysis should become evident at 3-5 d after infection. Productive infections can easily be observed using the GFP incorporated in pAdTrack-based vectors. m CRITICAL STEP Even though a relatively large volume of viral lysate is added to the flasks, there is no need to change the medium after infection. Note: Perform infection under BL2 conditions. 30| Remove tubes from ultracentrifuge and clamp onto a ring stand above a beaker of chlorine bleach. Note the position of the virus band, which appears as a narrow opaque white band approximately 1-2 cm below the mineral oil interface (Fig. 4b) . Collect virus fraction (approximately 0.5-1.0 ml) with a 3-ml syringe and 18-gauge needle by puncturing the side of the tube under the band to extract it into syringe (Fig. 4c) . Mix virus fraction with an equal volume of 2Â adenovirus storage buffer (2Â storage buffer ¼ 10 mM Tris, pH 8.0, 100 mM NaCl, 0.1% BSA and 50% glycerol; filter sterilized). Keep virus stocks at À80 1C. m CRITICAL STEP The thickness of a viral band on a CsCl gradient is determined by the efficiency of the final round of amplification.
22|
In an optimal infection, approximately 30-50% of the infected cells exhibit CPE 2 or 3 d after infection. If the infected cells exhibit significant CPE before 24 h or after 5 d following infection, the virus amplification was not optimal and the resultant viral titers are likely to be low. Thus, before the large-scale amplification, it is useful to perform a titration experiment to determine how much virus should be used in the final round. m CRITICAL STEP One can use an alternative two-stage CsCl banding procedure as follows. (i) Generate a CsCl gradient in a 17-ml Beckman polyallomer tube by placing 2.5 ml CsCl solution (density at 1.25 g ml À1 in 10 mM Tris-HCl, pH 8.0) in the tube and underlaying with 2.5 ml CsCl solution (density at 1.40 g ml À1 in 10 mM Tris-HCl, pH 8.0). Overlay 12-15 ml cleared viral lysate on top of the gradient and then add 300-500 ml mineral oil. Spin for 2 h at 26,000 r.p.m. in an SW28 rotor at 15 1C. Mature adenoviruses will concentrate at the junction of the two step gradients, whereas immature virus will concentrate in the 1.25 g ml À1 upper layer.
(ii) Harvest the virus band using an 18-gauge needle in a 5-10-cc syringe. Pool the virus band in a 15-ml tube. Calculate the density of the CsCl solution in which the virus band is found; this should be approximately 1.33 g ml À1 . Transfer the virus band to a 10-ml Beckman thick-wall polycarbonate centrifuge tube with cap and fill the tube with 1.33 g ml À1 CsCl solution. Centrifuge for 18 h at 15 1C in SW 65 rotor at 46 K r.p.m.
31| Determine viral titer by GFP expression, plaque assays or immunohistochemical staining using antibodies that detect the product of GOI. m CRITICAL STEP Although optical density provides an approximate index of viral yield, the results are less reliable than the functional tests described above. One OD unit (A 260 ) contains approximately 10 12 viral particles per ml (particles:infectious particles ¼ approximately 20:1). However, the OD 260 calculation is based on an estimate of viral DNA content and does not imply either competent viral packaging or transgene expression. m CRITICAL STEP The CsCl-purified high-titer adenovirus stocks should be stored at À80 1C in the CsCl solution described in Step 29, as viral particles are more stable in high-salt conditions. For in vitro applications where the virus stock is highly diluted (i.e., less than 1% of total medium volume), the purified virus preparation stored in this solution can be directly used. However, it is desirable to desalt the virus stocks via dialysis or size exclusion chromatography immediately before their use in applications wherein the CsCl is likely to be toxic (such as in animal experiments in vivo). ? TROUBLESHOOTING
TIMING
Step 
ANTICIPATED RESULTS
The AdEasy system has proved to be an efficient and robust technology for generating recombinant adenoviruses in thousands of laboratories worldwide. The key step is the generation of recombinants in AdEasier cells. Once these recombinants are obtained, generation of adenoviruses in HEK-293 cells is virtually guaranteed [23] [24] [25] [26] [27] . Depending on the transfection efficiency of HEK-293 cells, one can expect titers in the initial lysate to be 10 8 -10 10 pfu ml À1 . It usually requires two to three rounds of further amplification in HEK-293 cells to achieve viral titers of 10 12 or 10 13 pfu ml À1 . Cloning genes of interest into shuttle vectors entails standard molecular biology techniques. The user's experience in molecular cloning will determine the time required for this step. After subcloning GOI into a shuttle vector, the rate-limiting step is generally the production of the desired recombinants in AdEasier cells. With experience and high-quality competent AdEasier cells, it takes as few as 2 d to obtain and verify the recombinants.
If every step works well, one can expect to obtain the initial virus lysates 2-3 weeks thereafter and the subsequent largescale virus preparation in an additional 1-2 weeks (see TIMING). Further information can be found at the Internet resources listed in Box 1. Step Problem Possible cause(s) Possible solution(s)
